Related Articles
Reversal of multidrug resistance by the anti‑malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells
KD025, an anti‑adipocyte differentiation drug, enhances the efficacy of conventional chemotherapeutic drugs in ABCG2‑overexpressing leukemia cells